46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US
Publication
, Conference
Eng, C; Fakih, M; Sahin, IH; Lee, J; Chan, E; Rehn, M; Mesa Frias, MA; Strickler, JH
Published in: Annals of Oncology
July 2025
Duke Scholars
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
July 2025
Volume
36
Start / End Page
S28 / S28
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Eng, C., Fakih, M., Sahin, I. H., Lee, J., Chan, E., Rehn, M., … Strickler, J. H. (2025). 46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US. In Annals of Oncology (Vol. 36, pp. S28–S28). Elsevier BV. https://doi.org/10.1016/j.annonc.2025.05.058
Eng, C., M. Fakih, I. H. Sahin, J. Lee, E. Chan, M. Rehn, M. A. Mesa Frias, and J. H. Strickler. “46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US.” In Annals of Oncology, 36:S28–S28. Elsevier BV, 2025. https://doi.org/10.1016/j.annonc.2025.05.058.
Eng C, Fakih M, Sahin IH, Lee J, Chan E, Rehn M, et al. 46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US. In: Annals of Oncology. Elsevier BV; 2025. p. S28–S28.
Eng, C., et al. “46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US.” Annals of Oncology, vol. 36, Elsevier BV, 2025, pp. S28–S28. Crossref, doi:10.1016/j.annonc.2025.05.058.
Eng C, Fakih M, Sahin IH, Lee J, Chan E, Rehn M, Mesa Frias MA, Strickler JH. 46P Real-world first-line treatment outcomes of patients with KRAS G12C- or non- G12C KRAS mutated metastatic colorectal cancer in the US. Annals of Oncology. Elsevier BV; 2025. p. S28–S28.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
July 2025
Volume
36
Start / End Page
S28 / S28
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis